c="Ehlers-Danlos syndrome type IV" 1:0 1:3||t="problem"||cui="C0268338"||tot="Ehlers-Danlos Syndrome, Type IV"||ns="-1000"
c="Ehlers-Danlos syndrome type IV (EDS IV" 2:3 2:8||t="problem"||cui="C0268338"||tot="Ehlers-Danlos Syndrome, Type IV"||ns="-1000"
c="within the collagen III gene" 2:22 2:26||t="test"||cui="C1333079"||tot="Collagen Gene"||ns="-913"
c="COL3A1" 2:27 2:27||t="test"||cui="C1413581"||tot="COL3A1 gene"||ns="-1000"
c="glycine 400" 2:60 2:61||t="medication"||cui="C0017890"||tot="Glycine"||ns="-861"
c="glutamic acid" 2:63 2:64||t="medication"||cui="C0061472"||tot="Glutamic Acid"||ns="-1000"
c="glycine 595" 2:65 2:66||t="medication"||cui="C0017890"||tot="Glycine"||ns="-861"
c="glycine 1003" 2:70 2:71||t="medication"||cui="C0017890"||tot="Glycine"||ns="-861"
c="life-threatening disorder" 2:79 2:80||t="problem"||cui="C0012634"||tot="Disease"||ns="-827"
